摘要
目的观察C·A生物基因免疫重塑疗法治疗生殖器疱疹的疗效。方法 240例复发性生殖器疱疹患者随机分为两组,治疗组(120例)和对照组(120例),对照组口服阿昔洛韦片治疗,治疗组则在服用阿昔洛韦片的基础上加载C·A生物基因免疫重塑疗法治疗。观察患者临床症状及细胞免疫改善情况。结果治疗组成功率高达100.00%高于对照组的79.65%(P<0.05)。治疗后,治疗组IFN-γ、IL-2水平高于对照组,SIL-2R水平低于对照组(P<0.05)。跟踪随访结果显示,治疗组接受治疗后3、6、12个月复发率低于对照组(P<0.05)。结论C·A生物基因免疫重塑疗法通过对机体免疫系统的调节来治疗生殖器疱疹,具有治愈率高、复发率低的优点。
Objective To observe the efficacy of C·A biological gene immunotherapy for patients with genital herpe.Methods 240 cases of patients with recurrent genital herpe were randomly divided into two groups, treatment group （120 cases） and control group （120 cases）, control group were took aciclovir tablets oral treatment, treatment group were treated by both aciclovir tablets and C·A biological gene immunotherapy. Then the improvement of clinical symptoms and cellular immune of the two groups were compared.Results After ifnished all the therapy, the mission success rate of treatment group was 100.00% which was significantly higher than control group by 79.65% （P〈0.05）. The levels of IFN-γ, IL-2 of treatment group were higher than control group, while the SIL-2R was lower than control group （P〈0.05）. 3, 6, 12 months after treatment, the recurrence rate of treatment group was all lower than control group （P〈0.05）. Conclusion C·A biological gene immunotherapy has the advantages of high cure rate and low recurrence rate for genital herpes through the regulation of immune system of organism.
出处
《中国继续医学教育》
2015年第27期160-161,共2页
China Continuing Medical Education
